Kaposi Sarcoma in a Patient With Postpolio Syndrome

Article Type
Changed
Mon, 11/25/2019 - 12:44
Display Headline
Kaposi Sarcoma in a Patient With Postpolio Syndrome

Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000.1 The tumor is more common among certain groups of individuals due to geographic differences in the prevalence of KS-associated herpesvirus (also referred to as human herpesvirus 8) as well as host immune factors.2 Kaposi sarcoma often is defined by the patient's predisposing characteristics yielding the following distinct epidemiologic subtypes: (1) classic KS is a rare disease affecting older men of Mediterranean descent; (2) African KS is an endemic cancer with male predominance in sub-Saharan Africa; (3) AIDS-associated KS is an often aggressive AIDS-defining illness; and (4) iatrogenic KS occurs in patients on immunosuppressive therapy.3 When evaluating a patient without any of these risk factors, the clinical suspicion for KS may be low. We report a patient with postpolio syndrome (PPS) who presented with KS of the right leg, ankle, and foot. 

A 77-year-old man with a distant history of paralytic poliomyelitis presented for an annual skin examination with concern for a new lesion on the right ankle. The patient had a history of PPS primarily affecting the right leg. Physical examination revealed residual weakness in an atrophic right lower extremity with a mottled appearance and mild pitting edema to the knee. Two red, dome-shaped, vascular papules were appreciated on the medial aspect of the right ankle (Figure 1), and a shave biopsy of the larger papule was performed. Microscopic examination of the biopsy specimen was consistent with KS (Figure 2). This patient had no history of human immunodeficiency virus or immunosuppressive therapy and was not of Mediterranean descent. 

Figure 1. Vascular papules on the medial aspect of the right ankle with postpolio sequelae.

Figure 2. A, Microscopic examination showed a well-circumscribed hypercellular spindle cell dermal lesion with an epidermal collarette and peripheral vascular dilation (H&E, medium power). B, Immunohistochemical studies showed lesional cells positive for CD31 (medium power). C, Immunohistochemical studies showed lesional cells positive for human herpesvirus 8 (medium power).

Because KS is a radiosensitive vascular neoplasm and radiation therapy (RT) alone can achieve local control,4 the patient was treated with 6 megaelectron-volt electron-beam RT. He received 30 Gy in 10 fractions to the affected area of the medial ankle. The patient tolerated RT well. Three weeks after completing treatment, he was found to have mild lichenification on the right medial ankle with no clinical evidence of disease. Four months later, he presented with multiple additional vascular papules on the right third toe and in the interdigital web space (Figure 3). Shave biopsy of one of these lesions was consistent with KS. Contrast computed tomography of the chest, abdomen, and pelvis was performed, revealing no evidence of metastatic disease. The patient was treated with 30 Gy in 15 fractions using opposed lateral 6 megaelectron-volt photon fields to the entire right lower extremity below the knee to treat all of the skin affected by the PPS. His posttreatment course was complicated by edema in the affected leg that resolved after daily pneumatic compression. He had no evidence of residual or recurrent disease 6 months after completing RT (Figure 4). 

Figure 3. Recurrent vascular papules on the third toe before second course of radiotherapy.

Figure 4. No evidence of disease 6 months after the second course of radiotherapy.

Cutaneous KS is a human herpesvirus 8-positive tumor of endothelial origin typically seen in older men of Mediterranean or African descent and among immunosuppressed patients.4 Our patient did not have any classic risk factors for KS, but his disease did arise in the setting of a right lower extremity that was notably affected by PPS. Postpolio syndrome is characterized by muscle atrophy due to denervation of the motor unit.5 Bruno et al6 found that such deficits in motor innervation could lead to impairments in venous outflow causing cutaneous venous congestion. Acroangiodermatitis clinically resembles KS but is a benign reactive vasoproliferative disorder and is well known to occur in the lower extremities as a sequela of chronic venous insufficiency.7 A case of bilateral lower extremity pseudo-KS was reported in a patient with notable PPS.8 A report of 2 patients describes KS arising in the setting of chronic venous insufficiency without any classic risk factors.9 Therefore, patients with PPS characterized by venous insufficiency may represent a population at increased risk for KS. 
 

References
  1. Surveillance, Epidemiology, and End Results (SEER) Program. US Population Data--1969-2017. https://seer.cancer.gov/popdata/. Published January 2019. Accessed November 25, 2019. 
  2. Uldrick TS, Whitby D. Update on KSHV epidemiology, kaposi sarcoma pathogenesis, and treatment of saposi sarcoma. Cancer Lett. 2011;305:150-162. 
  3. Schwartz RA, Micali G, Nasca MR, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59:179-206. 
  4. Arnold HL, Odom RB, James WD, et al. Andrews' Diseases of the Skin: Clinical Dermatology. Philadelphia, PA: Saunders; 1990. 
  5. Boyer FV, Tiffreau V, Rapin A, et al. Post-polio syndrome: pathophysiological hypotheses, diagnosis criteria, drug therapy. Ann Phys Rehabil Med. 2010;53:34-41. 
  6. Bruno RL, Johnson JC, Berman WS. Vasomotor abnormalities as post-polio sequelae: functional and clinical implications. Orthopedics. 1985;8:865-869. 
  7. Palmer B, Xia Y, Cho S, Lewis FS. Acroangiodermatitis secondary to chronic venous insufficiency. Cutis. 2010;86:239-240. 
  8. Rotbart G. Kaposi's disease and venous insufficiency. Phlebologie. 1978;31:439-443. 
  9. Que SK, DeFelice T, Abdulla FR, et al. Non-HIV-related kaposi sarcoma in 2 Hispanic patients arising in the setting of chronic venous insufficiency. Cutis. 2015;95:E30-E33.
Article PDF
Author and Disclosure Information

From Duke University Medical Center, Durham, North Carolina. Drs. Whitley and Pavlis are from the School of Medicine, Dr. Barrow was from the Department of Pathology, Dr. Craciunescu is from the Department of Radiation Oncology, and Dr. Kirsch is from the Departments of Radiation Oncology and Pharmacology and Cancer Biology.

The author reports no conflict of interest.

Correspondence: David G. Kirsch, MD, PhD, Duke University Medical Center, Box 91006, Durham, NC 27708 (david.kirsch@duke.edu)

Issue
Cutis - 104(5)
Publications
Topics
Page Number
E20-E22
Sections
Author and Disclosure Information

From Duke University Medical Center, Durham, North Carolina. Drs. Whitley and Pavlis are from the School of Medicine, Dr. Barrow was from the Department of Pathology, Dr. Craciunescu is from the Department of Radiation Oncology, and Dr. Kirsch is from the Departments of Radiation Oncology and Pharmacology and Cancer Biology.

The author reports no conflict of interest.

Correspondence: David G. Kirsch, MD, PhD, Duke University Medical Center, Box 91006, Durham, NC 27708 (david.kirsch@duke.edu)

Author and Disclosure Information

From Duke University Medical Center, Durham, North Carolina. Drs. Whitley and Pavlis are from the School of Medicine, Dr. Barrow was from the Department of Pathology, Dr. Craciunescu is from the Department of Radiation Oncology, and Dr. Kirsch is from the Departments of Radiation Oncology and Pharmacology and Cancer Biology.

The author reports no conflict of interest.

Correspondence: David G. Kirsch, MD, PhD, Duke University Medical Center, Box 91006, Durham, NC 27708 (david.kirsch@duke.edu)

Article PDF
Article PDF
Related Articles

Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000.1 The tumor is more common among certain groups of individuals due to geographic differences in the prevalence of KS-associated herpesvirus (also referred to as human herpesvirus 8) as well as host immune factors.2 Kaposi sarcoma often is defined by the patient's predisposing characteristics yielding the following distinct epidemiologic subtypes: (1) classic KS is a rare disease affecting older men of Mediterranean descent; (2) African KS is an endemic cancer with male predominance in sub-Saharan Africa; (3) AIDS-associated KS is an often aggressive AIDS-defining illness; and (4) iatrogenic KS occurs in patients on immunosuppressive therapy.3 When evaluating a patient without any of these risk factors, the clinical suspicion for KS may be low. We report a patient with postpolio syndrome (PPS) who presented with KS of the right leg, ankle, and foot. 

A 77-year-old man with a distant history of paralytic poliomyelitis presented for an annual skin examination with concern for a new lesion on the right ankle. The patient had a history of PPS primarily affecting the right leg. Physical examination revealed residual weakness in an atrophic right lower extremity with a mottled appearance and mild pitting edema to the knee. Two red, dome-shaped, vascular papules were appreciated on the medial aspect of the right ankle (Figure 1), and a shave biopsy of the larger papule was performed. Microscopic examination of the biopsy specimen was consistent with KS (Figure 2). This patient had no history of human immunodeficiency virus or immunosuppressive therapy and was not of Mediterranean descent. 

Figure 1. Vascular papules on the medial aspect of the right ankle with postpolio sequelae.

Figure 2. A, Microscopic examination showed a well-circumscribed hypercellular spindle cell dermal lesion with an epidermal collarette and peripheral vascular dilation (H&E, medium power). B, Immunohistochemical studies showed lesional cells positive for CD31 (medium power). C, Immunohistochemical studies showed lesional cells positive for human herpesvirus 8 (medium power).

Because KS is a radiosensitive vascular neoplasm and radiation therapy (RT) alone can achieve local control,4 the patient was treated with 6 megaelectron-volt electron-beam RT. He received 30 Gy in 10 fractions to the affected area of the medial ankle. The patient tolerated RT well. Three weeks after completing treatment, he was found to have mild lichenification on the right medial ankle with no clinical evidence of disease. Four months later, he presented with multiple additional vascular papules on the right third toe and in the interdigital web space (Figure 3). Shave biopsy of one of these lesions was consistent with KS. Contrast computed tomography of the chest, abdomen, and pelvis was performed, revealing no evidence of metastatic disease. The patient was treated with 30 Gy in 15 fractions using opposed lateral 6 megaelectron-volt photon fields to the entire right lower extremity below the knee to treat all of the skin affected by the PPS. His posttreatment course was complicated by edema in the affected leg that resolved after daily pneumatic compression. He had no evidence of residual or recurrent disease 6 months after completing RT (Figure 4). 

Figure 3. Recurrent vascular papules on the third toe before second course of radiotherapy.

Figure 4. No evidence of disease 6 months after the second course of radiotherapy.

Cutaneous KS is a human herpesvirus 8-positive tumor of endothelial origin typically seen in older men of Mediterranean or African descent and among immunosuppressed patients.4 Our patient did not have any classic risk factors for KS, but his disease did arise in the setting of a right lower extremity that was notably affected by PPS. Postpolio syndrome is characterized by muscle atrophy due to denervation of the motor unit.5 Bruno et al6 found that such deficits in motor innervation could lead to impairments in venous outflow causing cutaneous venous congestion. Acroangiodermatitis clinically resembles KS but is a benign reactive vasoproliferative disorder and is well known to occur in the lower extremities as a sequela of chronic venous insufficiency.7 A case of bilateral lower extremity pseudo-KS was reported in a patient with notable PPS.8 A report of 2 patients describes KS arising in the setting of chronic venous insufficiency without any classic risk factors.9 Therefore, patients with PPS characterized by venous insufficiency may represent a population at increased risk for KS. 
 

Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000.1 The tumor is more common among certain groups of individuals due to geographic differences in the prevalence of KS-associated herpesvirus (also referred to as human herpesvirus 8) as well as host immune factors.2 Kaposi sarcoma often is defined by the patient's predisposing characteristics yielding the following distinct epidemiologic subtypes: (1) classic KS is a rare disease affecting older men of Mediterranean descent; (2) African KS is an endemic cancer with male predominance in sub-Saharan Africa; (3) AIDS-associated KS is an often aggressive AIDS-defining illness; and (4) iatrogenic KS occurs in patients on immunosuppressive therapy.3 When evaluating a patient without any of these risk factors, the clinical suspicion for KS may be low. We report a patient with postpolio syndrome (PPS) who presented with KS of the right leg, ankle, and foot. 

A 77-year-old man with a distant history of paralytic poliomyelitis presented for an annual skin examination with concern for a new lesion on the right ankle. The patient had a history of PPS primarily affecting the right leg. Physical examination revealed residual weakness in an atrophic right lower extremity with a mottled appearance and mild pitting edema to the knee. Two red, dome-shaped, vascular papules were appreciated on the medial aspect of the right ankle (Figure 1), and a shave biopsy of the larger papule was performed. Microscopic examination of the biopsy specimen was consistent with KS (Figure 2). This patient had no history of human immunodeficiency virus or immunosuppressive therapy and was not of Mediterranean descent. 

Figure 1. Vascular papules on the medial aspect of the right ankle with postpolio sequelae.

Figure 2. A, Microscopic examination showed a well-circumscribed hypercellular spindle cell dermal lesion with an epidermal collarette and peripheral vascular dilation (H&E, medium power). B, Immunohistochemical studies showed lesional cells positive for CD31 (medium power). C, Immunohistochemical studies showed lesional cells positive for human herpesvirus 8 (medium power).

Because KS is a radiosensitive vascular neoplasm and radiation therapy (RT) alone can achieve local control,4 the patient was treated with 6 megaelectron-volt electron-beam RT. He received 30 Gy in 10 fractions to the affected area of the medial ankle. The patient tolerated RT well. Three weeks after completing treatment, he was found to have mild lichenification on the right medial ankle with no clinical evidence of disease. Four months later, he presented with multiple additional vascular papules on the right third toe and in the interdigital web space (Figure 3). Shave biopsy of one of these lesions was consistent with KS. Contrast computed tomography of the chest, abdomen, and pelvis was performed, revealing no evidence of metastatic disease. The patient was treated with 30 Gy in 15 fractions using opposed lateral 6 megaelectron-volt photon fields to the entire right lower extremity below the knee to treat all of the skin affected by the PPS. His posttreatment course was complicated by edema in the affected leg that resolved after daily pneumatic compression. He had no evidence of residual or recurrent disease 6 months after completing RT (Figure 4). 

Figure 3. Recurrent vascular papules on the third toe before second course of radiotherapy.

Figure 4. No evidence of disease 6 months after the second course of radiotherapy.

Cutaneous KS is a human herpesvirus 8-positive tumor of endothelial origin typically seen in older men of Mediterranean or African descent and among immunosuppressed patients.4 Our patient did not have any classic risk factors for KS, but his disease did arise in the setting of a right lower extremity that was notably affected by PPS. Postpolio syndrome is characterized by muscle atrophy due to denervation of the motor unit.5 Bruno et al6 found that such deficits in motor innervation could lead to impairments in venous outflow causing cutaneous venous congestion. Acroangiodermatitis clinically resembles KS but is a benign reactive vasoproliferative disorder and is well known to occur in the lower extremities as a sequela of chronic venous insufficiency.7 A case of bilateral lower extremity pseudo-KS was reported in a patient with notable PPS.8 A report of 2 patients describes KS arising in the setting of chronic venous insufficiency without any classic risk factors.9 Therefore, patients with PPS characterized by venous insufficiency may represent a population at increased risk for KS. 
 

References
  1. Surveillance, Epidemiology, and End Results (SEER) Program. US Population Data--1969-2017. https://seer.cancer.gov/popdata/. Published January 2019. Accessed November 25, 2019. 
  2. Uldrick TS, Whitby D. Update on KSHV epidemiology, kaposi sarcoma pathogenesis, and treatment of saposi sarcoma. Cancer Lett. 2011;305:150-162. 
  3. Schwartz RA, Micali G, Nasca MR, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59:179-206. 
  4. Arnold HL, Odom RB, James WD, et al. Andrews' Diseases of the Skin: Clinical Dermatology. Philadelphia, PA: Saunders; 1990. 
  5. Boyer FV, Tiffreau V, Rapin A, et al. Post-polio syndrome: pathophysiological hypotheses, diagnosis criteria, drug therapy. Ann Phys Rehabil Med. 2010;53:34-41. 
  6. Bruno RL, Johnson JC, Berman WS. Vasomotor abnormalities as post-polio sequelae: functional and clinical implications. Orthopedics. 1985;8:865-869. 
  7. Palmer B, Xia Y, Cho S, Lewis FS. Acroangiodermatitis secondary to chronic venous insufficiency. Cutis. 2010;86:239-240. 
  8. Rotbart G. Kaposi's disease and venous insufficiency. Phlebologie. 1978;31:439-443. 
  9. Que SK, DeFelice T, Abdulla FR, et al. Non-HIV-related kaposi sarcoma in 2 Hispanic patients arising in the setting of chronic venous insufficiency. Cutis. 2015;95:E30-E33.
References
  1. Surveillance, Epidemiology, and End Results (SEER) Program. US Population Data--1969-2017. https://seer.cancer.gov/popdata/. Published January 2019. Accessed November 25, 2019. 
  2. Uldrick TS, Whitby D. Update on KSHV epidemiology, kaposi sarcoma pathogenesis, and treatment of saposi sarcoma. Cancer Lett. 2011;305:150-162. 
  3. Schwartz RA, Micali G, Nasca MR, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59:179-206. 
  4. Arnold HL, Odom RB, James WD, et al. Andrews' Diseases of the Skin: Clinical Dermatology. Philadelphia, PA: Saunders; 1990. 
  5. Boyer FV, Tiffreau V, Rapin A, et al. Post-polio syndrome: pathophysiological hypotheses, diagnosis criteria, drug therapy. Ann Phys Rehabil Med. 2010;53:34-41. 
  6. Bruno RL, Johnson JC, Berman WS. Vasomotor abnormalities as post-polio sequelae: functional and clinical implications. Orthopedics. 1985;8:865-869. 
  7. Palmer B, Xia Y, Cho S, Lewis FS. Acroangiodermatitis secondary to chronic venous insufficiency. Cutis. 2010;86:239-240. 
  8. Rotbart G. Kaposi's disease and venous insufficiency. Phlebologie. 1978;31:439-443. 
  9. Que SK, DeFelice T, Abdulla FR, et al. Non-HIV-related kaposi sarcoma in 2 Hispanic patients arising in the setting of chronic venous insufficiency. Cutis. 2015;95:E30-E33.
Issue
Cutis - 104(5)
Issue
Cutis - 104(5)
Page Number
E20-E22
Page Number
E20-E22
Publications
Publications
Topics
Article Type
Display Headline
Kaposi Sarcoma in a Patient With Postpolio Syndrome
Display Headline
Kaposi Sarcoma in a Patient With Postpolio Syndrome
Sections
Inside the Article

Practice Points

  • Cutaneous Kaposi sarcoma (KS) is a human herpesvirus 8–positive tumor of endothelial origin typically seen in older men of Mediterranean or African descent and among immunosuppressed patients.
  • In addition, patients with postpolio syndrome characterized by venous insufficiency may represent a population at increased risk for KS.
  • Kaposi sarcoma is a radiosensitive vascular neoplasm, and radiation therapy can achieve local control.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 11/25/2019 - 12:00
Un-Gate On Date
Mon, 11/25/2019 - 12:00
Use ProPublica
CFC Schedule Remove Status
Mon, 11/25/2019 - 12:00
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Painful Lesions on the Tongue

Article Type
Changed
Thu, 01/10/2019 - 13:29
Display Headline
Painful Lesions on the Tongue

The Diagnosis: Herpetic Glossitis

Oral lesions of the tongue are common during primary herpetic gingivostomatitis, though most primary oral herpes simplex virus (HSV) infections occur during childhood or early adulthood. Reactivation of HSV type 1 most commonly manifests as herpes labialis.1 When recurrent HSV involves intraoral lesions, they are typically confined to the gingiva and palate, sparing the tongue.

Clinical presentation of herpetic glossitis varies. Recurrent herpetic glossitis has been described in immunocompromised patients, particularly those with hematologic malignancies and organ transplants.2 In addition, immunocompromised and human immunodeficiency virus–infected patients may present with deep and/or broad ulcers. A case of herpes infection presenting with nodules on the tongue has been reported in Hodgkin disease.3 Herpetic geometric glossitis also has been described, which is a linear, crosshatched, or sharply angled branching with painful fissuring of the tongue. Herpetic geometric glossitis has been reported to occur in both immunocompetent and immunocompromised individuals.4 Tongue involvement during oral reactivation of HSV is exceedingly rare and the pathogenesis remains elusive, though one hypothesis proposes a protective role of salivary-specific IgA and lysozyme.5 Here, we report a case in which a patient developed similar lingual HSV lesions following recent immunosuppression.

References

 

1. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-121.

2. Nikkels AF, Piérard GE. Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol. 1999;140:343-346.

3. Leming PD, Martin SE, Zwelling LA. Atypical herpes simplex (HSV) infection in a patient with Hodgkin’s disease. Cancer. 1984;54:3043-3047.

4. Mirowski GW, Goddard A. Herpetic geometric glossitis in an immunocompetent patient with pneumonia. J Am Acad Dermatol. 2009;61:139-142.

5. Heineman HS, Greenberg MS. Cell protective effect of human saliva specific for herpes simplex virus. Arch Oral Biol. 1980;25:257-261.

Article PDF
Author and Disclosure Information

Dr. Connolly is from the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Dr. Pavlis is from Duke University, Durham, North Carolina. Dr. Moghaddam is from Stony Brook School of Medicine, New York.

The authors report no conflict of interest.

Correspondence: Sara Moghaddam, MD, 38394 Dupont Blvd, Unit FG, Selbyville, DE 19975 (smoghaddam@atlanticgeneral.org).

Issue
Cutis - 97(4)
Publications
Topics
Page Number
E4-E5
Legacy Keywords
herpes, herpetic glossitis
Sections
Author and Disclosure Information

Dr. Connolly is from the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Dr. Pavlis is from Duke University, Durham, North Carolina. Dr. Moghaddam is from Stony Brook School of Medicine, New York.

The authors report no conflict of interest.

Correspondence: Sara Moghaddam, MD, 38394 Dupont Blvd, Unit FG, Selbyville, DE 19975 (smoghaddam@atlanticgeneral.org).

Author and Disclosure Information

Dr. Connolly is from the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Dr. Pavlis is from Duke University, Durham, North Carolina. Dr. Moghaddam is from Stony Brook School of Medicine, New York.

The authors report no conflict of interest.

Correspondence: Sara Moghaddam, MD, 38394 Dupont Blvd, Unit FG, Selbyville, DE 19975 (smoghaddam@atlanticgeneral.org).

Article PDF
Article PDF

The Diagnosis: Herpetic Glossitis

Oral lesions of the tongue are common during primary herpetic gingivostomatitis, though most primary oral herpes simplex virus (HSV) infections occur during childhood or early adulthood. Reactivation of HSV type 1 most commonly manifests as herpes labialis.1 When recurrent HSV involves intraoral lesions, they are typically confined to the gingiva and palate, sparing the tongue.

Clinical presentation of herpetic glossitis varies. Recurrent herpetic glossitis has been described in immunocompromised patients, particularly those with hematologic malignancies and organ transplants.2 In addition, immunocompromised and human immunodeficiency virus–infected patients may present with deep and/or broad ulcers. A case of herpes infection presenting with nodules on the tongue has been reported in Hodgkin disease.3 Herpetic geometric glossitis also has been described, which is a linear, crosshatched, or sharply angled branching with painful fissuring of the tongue. Herpetic geometric glossitis has been reported to occur in both immunocompetent and immunocompromised individuals.4 Tongue involvement during oral reactivation of HSV is exceedingly rare and the pathogenesis remains elusive, though one hypothesis proposes a protective role of salivary-specific IgA and lysozyme.5 Here, we report a case in which a patient developed similar lingual HSV lesions following recent immunosuppression.

The Diagnosis: Herpetic Glossitis

Oral lesions of the tongue are common during primary herpetic gingivostomatitis, though most primary oral herpes simplex virus (HSV) infections occur during childhood or early adulthood. Reactivation of HSV type 1 most commonly manifests as herpes labialis.1 When recurrent HSV involves intraoral lesions, they are typically confined to the gingiva and palate, sparing the tongue.

Clinical presentation of herpetic glossitis varies. Recurrent herpetic glossitis has been described in immunocompromised patients, particularly those with hematologic malignancies and organ transplants.2 In addition, immunocompromised and human immunodeficiency virus–infected patients may present with deep and/or broad ulcers. A case of herpes infection presenting with nodules on the tongue has been reported in Hodgkin disease.3 Herpetic geometric glossitis also has been described, which is a linear, crosshatched, or sharply angled branching with painful fissuring of the tongue. Herpetic geometric glossitis has been reported to occur in both immunocompetent and immunocompromised individuals.4 Tongue involvement during oral reactivation of HSV is exceedingly rare and the pathogenesis remains elusive, though one hypothesis proposes a protective role of salivary-specific IgA and lysozyme.5 Here, we report a case in which a patient developed similar lingual HSV lesions following recent immunosuppression.

References

 

1. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-121.

2. Nikkels AF, Piérard GE. Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol. 1999;140:343-346.

3. Leming PD, Martin SE, Zwelling LA. Atypical herpes simplex (HSV) infection in a patient with Hodgkin’s disease. Cancer. 1984;54:3043-3047.

4. Mirowski GW, Goddard A. Herpetic geometric glossitis in an immunocompetent patient with pneumonia. J Am Acad Dermatol. 2009;61:139-142.

5. Heineman HS, Greenberg MS. Cell protective effect of human saliva specific for herpes simplex virus. Arch Oral Biol. 1980;25:257-261.

References

 

1. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-121.

2. Nikkels AF, Piérard GE. Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol. 1999;140:343-346.

3. Leming PD, Martin SE, Zwelling LA. Atypical herpes simplex (HSV) infection in a patient with Hodgkin’s disease. Cancer. 1984;54:3043-3047.

4. Mirowski GW, Goddard A. Herpetic geometric glossitis in an immunocompetent patient with pneumonia. J Am Acad Dermatol. 2009;61:139-142.

5. Heineman HS, Greenberg MS. Cell protective effect of human saliva specific for herpes simplex virus. Arch Oral Biol. 1980;25:257-261.

Issue
Cutis - 97(4)
Issue
Cutis - 97(4)
Page Number
E4-E5
Page Number
E4-E5
Publications
Publications
Topics
Article Type
Display Headline
Painful Lesions on the Tongue
Display Headline
Painful Lesions on the Tongue
Legacy Keywords
herpes, herpetic glossitis
Legacy Keywords
herpes, herpetic glossitis
Sections
Questionnaire Body

A 77-year-old man with a history of chronic obstructive pulmonary disease and recent pneumonia was treated with oral prednisone 40 mg daily, antibiotics, and a fluticasone-salmeterol inhaler. One week into treatment, the patient developed painful lesions limited to the oral cavity. Physical examination revealed many fixed, umbilicated, white-tan plaques on the lower lips, tongue, and posterior aspect of the oropharynx. The dermatology department was consulted because the lesions failed to respond to nystatin oral suspension.

Disallow All Ads
Alternative CME
Article PDF Media

Congenital Candidiasis: An Uncommon Skin Eruption Presenting at Birth

Article Type
Changed
Thu, 01/10/2019 - 13:14
Display Headline
Congenital Candidiasis: An Uncommon Skin Eruption Presenting at Birth

Article PDF
Author and Disclosure Information

Rick Siriratsivawong, MD; Michelle Pavlis, MD; Saul R. Hymes, MD; Jonathan P. Mintzer, MD

Issue
Cutis - 93(5)
Publications
Topics
Page Number
229-232
Legacy Keywords
congenital candidiasis, pediatric dermatology, neonatal skin eruption, Candida, neonatal disease, rashes in newborns
Sections
Author and Disclosure Information

Rick Siriratsivawong, MD; Michelle Pavlis, MD; Saul R. Hymes, MD; Jonathan P. Mintzer, MD

Author and Disclosure Information

Rick Siriratsivawong, MD; Michelle Pavlis, MD; Saul R. Hymes, MD; Jonathan P. Mintzer, MD

Article PDF
Article PDF
Related Articles

Issue
Cutis - 93(5)
Issue
Cutis - 93(5)
Page Number
229-232
Page Number
229-232
Publications
Publications
Topics
Article Type
Display Headline
Congenital Candidiasis: An Uncommon Skin Eruption Presenting at Birth
Display Headline
Congenital Candidiasis: An Uncommon Skin Eruption Presenting at Birth
Legacy Keywords
congenital candidiasis, pediatric dermatology, neonatal skin eruption, Candida, neonatal disease, rashes in newborns
Legacy Keywords
congenital candidiasis, pediatric dermatology, neonatal skin eruption, Candida, neonatal disease, rashes in newborns
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media